Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease.

BACKGROUND: Anticholinesterase therapies offer modest benefit to subgroups of AD sufferers. However, there has previously been no way of predicting which patients will respond to any of the drugs. OBJECTIVE: To discover if gender and/or apolipoprotein E genotype can be used as predictors of response...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: MacGowan, S, Wilcock, G, Scott, M
Materyal Türü: Journal article
Dil:English
Baskı/Yayın Bilgisi: 1998